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Abstract
Expression of the lineage-specific DNA-binding factor Foxp3 controls the development and function of naturally occurring
regulatory T cells. Foxp3 has been shown to interact with a multitude of transcriptional regulators including NFAT, NF-kB
(p65), Runx1 and RORct, as well as the histone modification enzymes TIP60, HDAC7 and HDAC9. The sum of these
interactions is believed to cause the change in the transcriptional program of regulatory T cells. Here we show that Foxp3
directly or as part of a multimeric complex engages with the NF-kB component c-Rel. We demonstrate that the N-terminal
region of Foxp3 is required for the binding of c-Rel, but not NFAT. Conversely, deletion of the forkhead domain causes a loss
of interaction with NFAT, but not c-Rel. Our findings are of particular interest, as c-Rel is crucial for the induction of Foxp3 in
regulatory T cells during thymic development, but has to be repressed in mature regulatory T cells to maintain their
suppressive phenotype.
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Introduction
The NF-kB family of transcription factors is coordinating the
expression of a wide variety of genes [1]. The expression of its
family member c-Rel is restricted to the haematopoietic and
lymphoid cell lineages. In T cells, it is an important mediator of
pro-inflammatory gene activation [1]. T cell receptor (TCR)
signaling in combination with CD28 co-stimulation leads to the
activation of c-Rel, resulting in the up-regulation of a variety of
pro-inflammatory cytokines such as IL-6, IL-12, IL-15 and IFN-c
[2]. Furthermore, c-Rel plays a key role in the transcriptional
activation of IL-2 [3,4]. Indeed, one of the defining features of c-
Rel deficient mutant mice is the severe abrogation of IL-2
expression in the T cell compartment [5]. Somewhat surprisingly,
c-Rel also appears to play a central role in the development of
regulatory T (TR) cells [6–12]. TCR signaling in thymic T cells
results in the formation of a c-Rel enhanceosome at the Foxp3
promoter. Foxp3 is exclusively expressed in regulatory T (TR) cells
and is considered to be a master regulator of TR cell function
[13,14]. It was initially thought to be a transcriptional repressor
[15], but it is now generally believed to work as both a repressor
and an activator [16–18]. It plays a key role in the development
and function of TR cells [19–21]. FOXP3 mutants in human
patients lack functional, thymically derived CD4
+CD25
+ regula-
tory TR cells and develop a severe systemic immune dysregulation,
polyendocrinopathy, enteropathy, X-linked syndrome (IPEX)
[22]. While lack of Foxp3 leads to a deficiency in functional TR
cells, ectopic expression of the gene in conventional TH cells leads
to a gain of TR cell phenotype [19,20].
The fact that the c-Rel is involved in both, the pro-
inflammatory transcriptional program and the opening of the
Foxp3 locus required for TR cells development appears to be
paradoxical. Indeed, over-expression of c-Rel in TR cells
handicaps their suppressive activity and function [7]. This suggests
that whilst c-Rel is required for the development of TR cells
through activation of Foxp3 transcription, its pro-inflammatory
activities have to be repressed in mature TR cells. The fact that
Foxp3 exerts its function by interacting with a variety of
transcription factors such as NFAT [18,23], Runx1 [24] and
RORct [25,26], all of which play important roles in the
development and function of conventional TH cells, makes it a
prime candidate for the suppression of c-Rel. Here we show that
Foxp3 interacts with c-Rel and thereby represses c-Rel mediated
NF-kB activation.
Results
Foxp3 inhibits c-Rel mediated NF-kB activation
To assess the role of Foxp3 in the suppression of c-Rel, we
transiently transfected 293ET cells with plasmids encoding (i) an
NF-kB-reporter m3p-firluc[NF-kB], (ii) an internal control
reporter pRL-TK, (iii) FLAG-tagged c-Rel (m5p[FLAG-c-Rel])
or p65 (m5p[FLAG-p65]) and (iv) increasing amounts of HA-
tagged Foxp3 (P8[HA-Foxp3]) or GFP as a control gene
(P8[control]). The resulting activity of firefly luciferase from the
NF-kB-reporter was normalized to the activity of renilla luciferase
arising from the control reporter. 48 h after transfection with
m5p[FLAG-p65] an ,8-fold induction of NF-kB activation was
observed, compared to cells transfected with P8[control] (Fig. 1A).
Transfection with m5p[FLAG-c-Rel] resulted in a ,2-fold
induction of NF-kB activation (Fig. 1B). To investigate the effect
of Foxp3 on NF-kB activation, we co-transfected increasing
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activation was only mildly affected by co-expression of Foxp3
(Fig. 1A), whereas c-Rel-mediated NF-kB activation was severely
inhibited (Fig. 1B). The difference in susceptibility to Foxp3-
mediated repression remained even when we lowered the amount
of m5p[FLAG-p65] used for the transfection (Fig. S1). While
Foxp3 appears to affect both p65 and c-Rel mediated NF-kB
activation, the effect on the latter is substantially more marked.
Foxp3 interacts with c-Rel
Next, we investigated whether the observed Foxp3-mediated
inhibition of NF-kB activity might be due to Foxp3 binding to c-
Rel. Using LUMIER assays with lysates prepared from 293ET
cells transiently transfected with m5p[FLAG-Foxp3] and m5p[luc-
c-Rel], we were able to detect an interaction between Foxp3 and
c-Rel, which was more marked in nuclear than cytoplasmic
extracts (Fig. 1C). Removal of the FKH domain (Foxp3
DFKH) led
to a substantial increase in the interaction detected in crude
lysates, which could be counteracted by the addition of a nuclear
localization signal (Foxp3
DFKH+NLS) to Foxp3
DFKH (Fig. 1D).
Together the data suggest that Foxp3, directly or as part of a
multimeric complex interacts with c-Rel in a FKH independent
fashion. Indeed, deletion of the FKH domain leads to an increase
in the amount of protein in the cytoplasm and thus appears to
facilitate the interaction between the proteins.
Regions of Foxp3 required for interaction with c-Rel
To further characterize the interaction between Foxp3 and c-Rel
we performed a mutational analysis of Foxp3, assessing the domains
required for the interaction between the two proteins. As before, we
used LUMIER assays with total cell lysates prepared from 293ET
cells transiently transfected with the various Foxp3 mutants
(m5p[FLAG-Foxp3
mut]) and m5p[luc-c-Rel]. As we had already
established that the FKH domain was dispensable for binding to
c-Rel, we based the various deletion and point mutants on
Foxp3
DFKH (Fig. 2). Deletion of exon 1 (Foxp3
DFKH: De1) was
sufficient to almost entirely abrogate c-Rel binding (Fig. 2). Deletion
of exon 6, which contains a coiled-coil (Foxp3
DFKH: De6), abolished
binding altogether, suggesting that dimerization of Foxp3 is
required. In contrast, individual deletions of exons 2 or 3 only
partially reduced binding. No interaction between Foxp3
DFKH: De5
and c-Rel could be detected, but this particular mutant was
expressed poorly (Fig. 2, arrow) making an interpretation of this
result all but impossible. Deletion of exon 8 (Foxp3
DFKH: De8), which
has been reported to be involved in Runx1 binding [24], also led to
a loss of interaction between c-Rel and Foxp3.
The transactivation domain of c-Rel is required for
interaction with Foxp3
c-Rel, like p65, belongs to the NF-kB family of proteins, which
are defined by highly conserved N-terminal DNA-binding
Figure 1. Foxp3 inhibits c-Rel mediated NF-kB activity. (A-B) 293ET cells were transfected with 400 ng of (A) m5p[FLAG-p65] or (B) m5p[FLAG-
c-Rel] together with 50 ng of the NF-kB-reporter (firefly) m3p-luc[NF-kB], 20 ng pRL-TK and increasing amounts of P8[HA-Foxp3] or GFP as a control
gene (P8[control]) as indicated. Forty-eight hours later, the cells were analyzed for NF-kB activity, which was normalized against the renilla luciferase
signal. Transfections were performed in duplicate wells and two samples were measured in each case (***=p,0.001, ANOVA). (C) 293ET cells were
co-transfected with m5p[luc-c-Rel] and m5p[FLAG-Foxp3] or GFP as a control gene m5p[FLAG-control]. Forty-eight hours later cytoplasmic and
nuclear cell lysates were prepared and the interaction between the two proteins were measured using LUMIER assays. (D) 293ET cells were
co-transfected with m5p[luc-c-Rel] and m5p[FLAG-Foxp3
mut] or FLAG-GFP as a control gene m5p[FLAG-control]. Forty-eight hours later total cell
lysates were prepared and used for LUMIER assays. (A–D) In each case the experiment was repeated three times and a representative example is
shown. The error-bars represent the SEM.
doi:10.1371/journal.pone.0018670.g001
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sequestered in the cytoplasm as homo- or heterodimers through
association with IkB, which binds to their IPT (Ig-like-plexins-
transcription factors) domains [27,28]. The C-termini of c-Rel and
p65 contain non-conserved transactivation domains, which
interact with various components of the basal transcription
apparatus [28,29].
To map the regions of c-Rel required for Foxp3 binding, we
performed LUMIER assays with lysates prepared from 293ET
cells transiently transfected with m5p[FLAG-Foxp3
DFKH] and
various c-Rel mutants (m5p[luc-c-Rel
mut]). Deletion of the N-
terminal 167 amino acids (c-Rel
118-588) did not affect the
interaction of c-Rel with Foxp3
DFKH, indicating that the RHD is
not required for the interaction (Fig. 3). However, if the deletions
extended to the IPT domain (c-Rel
221-588 and c-Rel
278-588) the
interaction with Foxp3
DFKH was abolished. Likewise, a C-terminal
deletion of the last 63 amino acids of c-Rel (c-Rel
1-525) was
sufficient to severely compromise binding to Foxp3
DFKH and
further deletion of the transactivation domain (c-Rel
1-399 and c-
Rel
1-287) completely abolished the interaction between the two
proteins (Fig. 3). This suggest, that c-Rel binds to Foxp3 via its C-
terminal transactivation domain and the loss of binding in the
absence of the entire RHD and IPT indicates that dimerization of
c-Rel is required.
c-Rel binding to Foxp3 is not required for its interaction
with NFAT
Foxp3 has been described to form a complex with NFAT via its
FKH domain [18]. Mutations that were predicted to disrupt the
interaction between the two proteins, interfered with the ability of
Foxp3 to inhibit the expression of several cytokines, including IL-
2, and to up-regulate TR cell associated markers such as CD25
and CTLA-4 [18]. However, an N-terminal deletion mutant of
Foxp3 was also incapable of performing these functions, suggesting
that binding of further factors might be required [18]. It remained
unclear whether this is facilitated through interaction with a
different region of NFAT or whether this is independent of NFAT
[18]. To test whether the N-terminal region of Foxp3 is involved in
NFAT binding, we performed a mutational analysis of Foxp3
assessing the domains required for this interaction. As previously
shown [18], we found that deletion of the FKH domain
(Foxp3
DFKH) abrogated NFAT binding (Fig. 4). In contrast,
deletion of exon 1 (Foxp3
De1) had no effect on the interaction
between the two proteins. As was the case for c-Rel binding, the
deletion of the coiled-coil of Foxp3 (Foxp3
De6) had a marked effect
on NFAT binding. Individual deletions of all other exons led only
to a partial reduction in the interaction between Foxp3 and NFAT
(Fig. 4). In agreement with previous studies [18], this shows that
the FKH is required for NFAT binding, whereas the N-terminal
region is dispensable for complex formation between the two
proteins. Furthermore, this indicates that the interaction of Foxp3
with c-Rel can occur in the absence of its interaction with NFAT
and vice versa.
The N-terminal region of Foxp3 is required for NF-kB
repression
Our data suggests that the N-terminal region plays a crucial role
in c-Rel binding, but is not required for NFAT interaction, which
binds to the FKH domain. Thus, we investigated the role of these
domains in repressing c-Rel mediated NF-kB activity. We
transiently transfected 293ET cells with the NF-kB reporter
plasmid and the relevant Foxp3 mutant, as described above.
Deletion of exon 1 (Foxp3
De1), which disrupts c-Rel binding
(Fig. 2), led to a marked, albeit not complete, reduction in the
repression of c-Rel induced NF-kB activation (Fig. 5A). Disruption
of NFAT binding through the deletion of the FKH domain
(Foxp3
DFKH) had only a minor effect on the potency of the
repression of c-Rel mediated NF-kB activation (Fig. 5B).
c-Rel causes a shuttling of Foxp3
DFKH into the nucleus
We were intrigued to find that Foxp3
DFKH, despite having lost
its nuclear localization [30], was still capable of regulating c-Rel
mediated NF-kB activation. As Foxp3 is a DNA binding factor, we
would have expected that nuclear localization is a prerequisite for
its activity as a transcriptional regulator [31]. We hypothesized
that either Foxp3
DFKH retains c-Rel in the cytoplasm or c-Rel
shuttles Foxp3
DFKH into the nucleus. To test this, we transfected
293ET cells with plasmids encoding c-Rel (m5p[c-Rel]) and a
GFP-tagged Foxp3
DFKH (m5p[GFP-Foxp3
DFKH]) and analyzed
the sub-cellular localization of GFP-Foxp3
DFKH by confocal
microscopy. In 293ET cells a large proportion of ectopically
expressed c-Rel localizes to the nucleus in the absence of any kind
Figure 2. Regions of Foxp3 required for the interaction with c-Rel. 293ET cells were co-transfected with m5p[luc-c-Rel] and various
m5p[FLAG-Foxp3
DFKH:mut] as shown in the schematic on the left. Forty-eight hours later total cell lysates were prepared and used in LUMIER assays.
Cell lysates were precipitated using anti-FLAG agarose. Fold binding indicates the ratio of luciferase activity in precipitates and cell lysates normalized
to a control (GFP) reaction. Total cell lysates were analyzed by Western Blots (insert) for the expression of the FLAG-tagged Foxp3
DFKH:mut proteins.
Foxp3
DFKH: De5 is only expressed at very low levels (arrow). A representative example of three independent experiments is shown. The error-bars
represent the SEM within the experiment. ZnF = zinc finger, CC = coiled-coil.
doi:10.1371/journal.pone.0018670.g002
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GFP-Foxp3
DFKH was predominantly found in the cytoplasm
(Fig. 5C), co-expression of c-Rel caused a redistribution of GFP-
Foxp3
DFKH into the nucleus (Fig. 5D). Notably, deletion of either
the RHD (c-Rel
168-588) or transactivation domain (c-Rel
1-287)o fc -
Rel led to a loss of this redistribution (Fig. 5E). The former causes
a loss of nuclear translocation of c-Rel [1], whereas the latter leads
to a loss of Foxp3 binding (Fig. 3). Wild type Foxp3 is already
nuclear by itself and co-transfection of c-Rel didn’t change this
(data not shown).
Discussion
Here we show that Foxp3 either directly or as part of a larger
multimeric complex [32] interacts with c-Rel. We found that
deletion of the N-terminal region of Foxp3 led to a loss of
inhibition of c-Rel-mediated NF-kB activity. Furthermore, we
demonstrate that this region is required for binding of the
transactivation domain of c-Rel, which interacts with components
of the basal transcription apparatus such as TATA-binding
proteins, p300 and cyclic-AMP-response element (CREB)-binding
protein (CBP) [33]. An attractive interpretation would be that
Foxp3 competes with such factors for binding, which would result
in an inhibition of transcription. However, simple competition for
interaction with c-Rel is unlikely to be the entire explanation, as
while Foxp3
DFKH is still capable of binding c-Rel, it has lost the
ability to inhibit IL-2 expression [18].
In the case of IL-2 and several other Foxp3 target genes, NFAT
is an essential component of transcriptional control [18]. In
the absence of Foxp3, both c-Rel and NFAT activate IL-2
transcription [34], whereas in the presence of Foxp3 both appear
to be involved in its repression. Foxp3
De1 binds NFAT, but has lost
its ability to interact with c-Rel. Conversely Foxp3
DFKH interacts
with c-Rel, but not NFAT. This demonstrates that either factor
can bind to Foxp3 without the other being present, suggesting that
in some cases the individual interactions might be sufficient for the
regulation of target gene transcription. However, we observed an
increase in the binding of c-Rel to Foxp3 when we deleted its FKH
and thereby interfered with NFAT binding. However, as this also
leads to a repositioning of Foxp3 into the cytoplasm, an
experimental bias favoring an interaction with c-Rel might be
introduced. An alternative interpretation would be that under
physiological conditions c-Rel and NFAT directly or indirectly
compete for binding to Foxp3.
While we found that c-Rel can shuttle Foxp3
DFKH into the
nucleus, this might not always be sufficient to reconstitute its
function. Indeed, it has already been shown that the FKH is crucial
for nuclear localization, DNA binding as well as interaction with
NFAT [18]. We consider the shuttling of Foxp3
DFKH by c-Rel to be
an experimental peculiarity. Nevertheless, it points towards a
potential role of c-Rel in transporting Foxp3 towards particular
target genes, which warrants further investigations in future.
Foxp3 and c-Rel predominantly exist as dimers. In the case of
Foxp3, this is mediated by the coiled-coil [35]. Point mutations
found in IPEX patients, which lie in critical residues (DK249 or
DE250) within the coiled-coil, are defective in dimerization and
lead to a loss of Foxp3 function [35]. For c-Rel, the dimerization is
dependent on the presence of the IPT domain [36]. We show that
disruption of either the coiled-coil in Foxp3 or IPT in c-Rel leads
to a loss of complex formation between the proteins. This suggests
Figure 3. The C-terminal transactivation domain of c-Rel is required for the interaction with Foxp3. (A–C) 293ET cells were
co-transfected with m5p[FLAG-Foxp3
DFKH] and various m5p[luc-c-Rel
mut] as shown in the schematic on the left. Forty-eight hours later total cell
lysates were prepared and used in LUMIER assays. Cell lysates were precipitated using anti-FLAG agarose. (A) Fold binding indicates the ratio of
luciferase activity in precipitates and cell lysates normalized to a control (GFP) reaction. (B) Total cell lysates were analyzed by Western Blots (insert)
for the expression of the FLAG-tagged Foxp3
DFKH protein. (C) Total luciferase activity in lysate to show the expression of luc-c-Rel
mut. A representative
example of three independent experiments is shown. The error-bars represent the SEM within the experiment.
doi:10.1371/journal.pone.0018670.g003
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to interact.
We found that while the FKH domain of Foxp3 is not necessary
for c-Rel binding, deletion of exon 8, lying immediately upstream of
the FKH is. This region of Foxp3 is required for its interaction with
the transcription factor Runx1, which also has been implicated in
IL-2 regulation [24]. However, we cannot exclude that the
progressive deletion of the C-terminus of Foxp3 leads to a loss of
structural integrity per se, rather than invoking a requirement for
cooperative binding of Runx1 and c-Rel.
It has been proposed that Foxp3 forms high molecular weight,
multimeric transcriptional complexes [32]. From this, and other
Figure 4. The forkhead domain of Foxp3 interacts with NFAT. (A–C) 293ET cells were co-transfected with m5p[FLAG-NFAT] and various
m5p[luc-Foxp3
mut] as shown in the schematic on the left. Forty-eight hours later total cell lysates were prepared and used in LUMIER assays. Cell
lysates were precipitated using anti-FLAG agarose. (A) Fold binding indicates the ratio of luciferase activity in precipitates and cell lysates normalized
to a control (GFP) reaction. (B) Total cell lysates were analyzed by Western Blots for the expression of the FLAG-tagged NFAT proteins. (C) Total
luciferase activity in lysate to show the expression of luc-Foxp3
mut. A representative example of three independent experiments is shown. The error-
bars represent the SEM within the experiment.
doi:10.1371/journal.pone.0018670.g004
Figure 5. c-Rel causes a shuttling of Foxp3
DFKH into the nucleus. (A) 293ET cells were transfected with 400 ng m5p[c-Rel], 50 ng m3p-luc
[NF-kB], 20 ng pRL-TK and increasing amounts of P8[Foxp3] or P8[Foxp3
De1]. Two independent experiments were performed and fold NF-kB
activation was pooled and normalized against the highest signal. The error-bars represent the SEM, (***=p,0.001; two-way ANOVA). (B)
Alternatively, the cells were transfected with 50 ng m3p-luc[NF-kB], 20 ng pRL-TK and 400 ng P8[control] (GFP), P8[Foxp3] or P8[Foxp3
DFKH] in the
presence or absence of 400 ng m5p[c-Rel]. Forty-eight hours later, the cells were analyzed for NF-kB activity, which was normalized against the renilla
luciferase signal (***=p,0.001; unpaired t test). (C-E) 293ET cells were co-transfected with m5p[GFP-Foxp3
DFKH] in the (C) absence or (D) presence of
m5p[c-Rel] and analyzed by confocal microscopy after 48 h. (E) Pooled data from two independent experiments where 293ET cells were co-
transfected with m5p[GFP-Foxp3
DFKH] and rel-homology domain deletion (c-Rel
168-588) or transactivation domain deletion (c-Rel
1-287) of c-Rel. For
each of the conditions, several randomly picked field of visions (,10 cells) were scored for the presence of Foxp3
DFKH in the nucleus. As a control,
cells were transfected with rCD8a (m5p[control]) (***=p,0.001; unpaired t test).
doi:10.1371/journal.pone.0018670.g005
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Foxp3 works by hijacking already resident transcriptional
mechanisms that are important for T cell activation. In particular
the N-terminal region has been shown to interact with many
factors including RORct, RORa [25,26], Tip60, HDAC7/9 [37]
and Eos [38]. It might well be that the composition of these
complexes differs depending on the developmental stage and
activation status of the cell, as well as the target gene. In some
cases, the presence of Foxp3 may lead to a switch from gene
activation to repression, and in others it may lead to enhanced
transcription. This might explain how a single factor, Foxp3, can
redirect the transcriptional program from that of a pro-
inflammatory TH cell to that of a suppressive TR cell - two
diametrically opposed immunological T cell functions.
Materials and Methods
Cells
293ET human embryonic kidney cells [39] were grown in
IMDM supplemented with 10% FCS 50 mM b-mercaptoethanol
and 50 mg/ml gentamicin. Eighteen hours prior to transfection,
293ET cells were seeded into plates at a density of 1.5610
5 cells/
cm
2. Transfections were performed using standard calcium
phosphate precipitation.
Plasmids
In most experiments, the low expressing plasmid m5p was used
[40]. For the measurement of NF-kB activation, a 8xNF-kB-
Luciferase (Firefly) reporter (m3p-firluc[NF-kB]), as well as high-
expressing pEAK8-based plasmids expressing Foxp3 (P8[Foxp3])
or GFP as an irrelevant control gene (P8[control]) were used.
NF-kB reporter assays
293ET cells were seeded and eighteen hours later the cells were
transfected with 50 ng of m3p-firluc[NF-kB], 20 ng of pRL-TK
control vector and the indicated plasmids. The transfected cells
were analyzed 48 h later using the Dual Luciferase Reporter Assay
system (Promega) following the manufacturer’s instructions.
Preparation of cytoplasmic and nuclear extracts
Preparation of 293ET extracts was performed on ice and all
centrifugations were performed at 4uC. Crude lysates were
prepared by addition of lysis buffer (20 mM Tris, 150 mM NaCl,
5 mM EDTA, 0.1% Triton X-100, 10% glycerol, 5 mg/ml
leupeptin, 2 mg/ml aprotinin, 1 mM benzamidine, 1 mM PMSF)
and incubation for 15 minutes. The extracts were cleared by
centrifugation at 16000 xg for 15 minutes. Where cytoplasmic and
nuclear extracts were required, cells were collected, washed with
PBS and lysed in hypotonic buffer (10 mM HEPES pH 7.9,
10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT,
5 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM benzamidine, 1 mM
PMSF) for 5 minutes. NP-40 was added to a final concentration of
0.6%, the cells were vortexed briefly and nuclei were collected by
centrifugation at 16000 xg for 1 minute. The nuclear pellet was
vortexed for 15 minutes in cold hypertonic buffer (20 mM HEPES
pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT,
5 mg/ml leupeptin, 2 mg/ml aprotinin, 1 mM benzamidine, 1 mM
PMSF) to release nuclear proteins. Following centrifugation at
16000 xg for 15 minutes, the supernatant was collected and where
necessary, the protein concentration was quantified using
Bradford (BIO-RAD). Unless used directly, the extracts were
stored at -70uC.
Luminescence-based mammalian interactome mapping
(LUMIER)
293ET cells were co-transfected with a FLAG-tagged construct
and a Renilla Luciferase-tagged construct. Extracts were incubat-
ed with anti-FLAG M2 Affinity Gel (Sigma) for 2 h, rotating at
4uC. Unbound protein was removed by washing 5 times with
20 mM Tris, 150 mM NaCl, 5 mM EDTA, 0.1% Triton X-100,
10% glycerol and centrifugation at 6000 xg for 30 seconds. Bound
proteins were eluted from the affinity gel by incubating with
150 mg/ml FLAG peptide (Sigma) for 30 minutes, rotating at 4uC.
A sample of the lysate (input) and a sample of the gel eluate
(immunoprecipitated) were measured for Renilla Luciferase
activity using the Renilla Luciferase Assay Kit (Promega) as
described in the manufacturer’s protocol. The results are shown as
the ratio of immunoprecipitated versus input Renilla Luciferase
activity.
Western blots
Extracts were separated on NuPAGE 4-12% Bis-Tris gels
(Invitrogen) and blotted onto nitrocellulose membrane (Whatman)
as described by the manufacturer. The membrane was blocked for
1 h at room temperature with 3% milk and incubated at 4uC
overnight with one of the following antibodies: 1:1000 of rabbit
anti-c-Rel (sc-71, Santa Cruz Biotechnology), 1:5000 of mouse
anti-FLAG M2 (Sigma), 1:1000 of mouse anti-HA.11 (Covance
Research Products). The membrane was washed and incubated
with anti-mouse or anti-rabbit HRP-conjugated secondary
antibody (DakoCytomation) for 2 h at room temperature. HRP
was detected by incubation of the membrane with ECL Detection
Reagents (Amersham Biosciences).
Translocation of Foxp3
DFKH
293ET cells were co-transfected with m5p[GFP-Foxp3
DFKH]i n
the presence or absence of m5p[c-Rel]. Twenty-four hours later,
1610
4 cells were transferred into Lab-Tec chambered coverslips
(Nalge Nunc International). After an additional 24 h, the sub-
cellular localization was assessed by observing for cytosolic and
nuclear presence of GFP-Foxp3
DFKH by using a BioRad Radiance
2000 confocal microscope.
Supporting Information
Figure S1 Foxp3-mediated repression of NF-kB activity.
293ET cells were transfected with 400 ng of m5p[FLAG-c-Rel] or
100 ng of m5p[FLAG-p65] together with 50 ng of the NF-kB-
reporter (firefly) m3p-luc[NF-kB], 20 ng pRL-TK and increasing
amounts of P8[HA-Foxp3]. Forty-eight hours later, the cells were
analyzed for NF-kB activity, which was normalized against the
renilla luciferase signal.
(TIF)
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